Simple Summary This study investigates the association between routine medical imaging
and digitalized scans in lung cancer patients treated with immunotherapy. It involves …

Objective We aimed to identify imaging biomarkers to assess predictive capacity of
radiomics nomogram regarding treatment response status (responder/non-responder) in …

Background Although immunotherapy has revolutionized the field of cancer treatment,
response rates are only∼ 20% in non-small cell lung cancer (NSCLC) patients and cost of …

Growing evidence suggests that the efficacy of immunotherapy in non-small cell lung
cancers (NSCLCs) is associated with the immune microenvironment within the tumor. We …

Background An abundance of CD8+ tumor infiltrating lymphocytes (TILs) in the center of
solid tumors is a reliable predictive biomarker for patients eligible for immunotherapy …

Simple Summary The objective of the study was to assess the radiomics features obtained
by computed tomography (CT) examination as biomarkers in order to select patients with …

Simple Summary In locally advanced or metastatic non-small cell lung cancer (NSCLC),
immunotherapy has become a standard as it can improve overall survival and progression …

With increasing use of immunotherapy agents, pretreatment strategies for identifying
responders and non-responders is useful for appropriate treatment assignment. We …

To develop a short-term follow-up CT-based radiomics approach to predict response to
immunotherapy in advanced non-small-cell lung cancer (NSCLC) and investigate the …

Immunotherapies have revolutionised cancer management. Despite their success, durable
responses are limited to a subset of patients. Prediction of immunotherapy response in …